Total planned funding: $87,465,099
Allocations
Countries/Regions
India | $87,465,099 |
Organizational Types
Unknown | $45,026,637 |
NGO | $19,595,145 |
Own Agency | $12,276,509 |
University | $3,200,000 |
Implementing Agency | $3,100,000 |
Multi-lateral Agency | $1,956,808 |
Private Contractor | $1,509,000 |
Host Country Government Agency | $601,000 |
FBO | $200,000 |
Other USG Agency | $0 |
Program Areas
Governance and Systems | $48,039,072 |
Prevention | $14,991,913 |
Management and Operations | $9,383,514 |
Treatment | $3,839,618 |
Care | $3,756,883 |
Testing | $3,026,307 |
Budget Codes
OHSS: Health Systems Strengthening | $29,333,209 |
HVSI: Strategic Information | $15,799,939 |
HVMS: Management and Operations | $9,383,514 |
HVOP: Sexual Prevention: Other Sexual Prevention | $6,396,132 |
HTXS: Treatment: Adult Treatment | $3,732,758 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $3,692,053 |
HVCT: Testing: HIV Testing and Counseling | $3,026,307 |
HLAB: Laboratory Infrastructure | $2,905,924 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $2,361,076 |
HBHC: Care: Adult Care and Support | $1,665,034 |
HKID: Care: Orphans and Vulnerable Children | $1,537,166 |
HMBL: Biomedical Prevention: Blood Safety | $1,474,026 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $1,068,626 |
HVTB: Care: TB/HIV | $484,683 |
PDTX: Treatment: Pediatric Treatment | $106,860 |
PDCS: Care: Pediatric Care and Support | $70,000 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Not Available:
$45,026,637
Countries/Regions
FHI 360:
$14,287,057
Countries/Regions
USG Aggregated Agencies:
$9,702,094
Countries/Regions
University of Washington:
$3,200,000
Countries/Regions